2022
DOI: 10.1016/j.clinsp.2022.100073
|View full text |Cite
|
Sign up to set email alerts
|

Impact of SARS-CoV-2 on pregnancy and neonatal outcomes: An open prospective study of pregnant women in Brazil

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 28 publications
0
4
0
Order By: Relevance
“…Previously, Gomez et al [24] evaluated all cases of SARS-CoV-2 among pregnant women from our institution, finding that more severe cases had larger body mass index and higher prevalence of systemic hypertension. Further, authors described that most severe cases were associated with preterm birth, fetal distress, and maternal and neonatal death as compared to mild and moderate cases [24].…”
Section: Discussionmentioning
confidence: 91%
“…Previously, Gomez et al [24] evaluated all cases of SARS-CoV-2 among pregnant women from our institution, finding that more severe cases had larger body mass index and higher prevalence of systemic hypertension. Further, authors described that most severe cases were associated with preterm birth, fetal distress, and maternal and neonatal death as compared to mild and moderate cases [24].…”
Section: Discussionmentioning
confidence: 91%
“…Unexpectedly, we also found that the prevalence of primigravida was significantly higher in positive COVID-19 women compared with age-matched healthy controls. A previous study indicated that primigravida was not associated with severe maternal outcomes among positive pregnant women (Vouga et al, 2021) whereas Trovato-Gomez et al reported that primigravida decreased the risk of severe COVID-19 (Gomez et al, 2022). These inconclusive findings might be due to differences in gestational age and the severity of the diseases, since in the study of Vouga et al, all pregnant women were tested for SARS-CoV-2 infection at any stage of gestation (Vouga et al, 2021).…”
Section: Discussionmentioning
confidence: 98%
“…Placental findings were compared with clinical parameters of the severity of COVID-19, and the cases were divided into three groups according to the severity of the disease: mild, women with no symptoms or when there was no need for ventilatory support; moderate, symptomatic women with need for hospitalization (SpO2 <94% and/or respiratory rate >24 breaths per minute) and in the hospital admission with the need for supplemental oxygen delivered by a simple catheter and severe was defined as a hospital admission with the need for admission in the ICU (i.e., supplemental oxygen delivered in forms other than simple catheter [e.g., venturi mask] and/or organ involvement), using an adapted version of the classification proposed by the Ministry of Health of Brazil [ 15 , 16 ]. The evaluated obstetric parameters were: oligohydramnios (defined as amniotic fluid index <5), preeclampsia, and gestational diabetes.…”
Section: Methodsmentioning
confidence: 99%